Science News

License To Kill: Development Of Killer T Cells Observable

ScienceDaily (Nov. 25, 1999)New Model Could Show How Immune System is Thwarted By HIV and Cancer

Boston, MA--November 22, 1999--Researchers at the Center for Blood Research and Harvard Medical School report in the November 23 Proceedings of the National Academy of Sciences the development of an animal model that literally illuminates one of the most dramatic and, until now, obscure events in the body: how the immune system turns immature T cells into specialized killer, or cytotoxic, T cells, capable of seeking out and destroying cells maimed by cancer and infection.

"Now, we have a model that makes it possible to look at a unique and important subset of cells; first to identify it and then analyze it in novel ways," says Ulrich von Andrian, MD, PhD, HMS associate professor of pathology. "This system might allow us to get a better understanding of what provides the T cells' license to kill," he says. Ultimately, the model could be used to clarify such diseases as cancer and AIDS. Some researchers have suspected that viruses and tumor cells may thwart the immune system by taking away T cells' license to kill—that is, by sabotaging the cellular machinery that enables them to attack unwanted cells.

"During the initial stages of an HIV infection, there are lots of cytotoxic T cells in the body but, for some reason, they are not able to contain the infection," says N. Manjunath, PhD, research fellow, and lead author of the study. "Is there a defect in these cells? Understanding normal differentiation with our new model, we might help answer this question."

One of the biggest obstacles to understanding this crucial transformation has been spotting members of this elite corps in large enough numbers to study them. Relatively rare—white blood cells in general number about one in one thousand cells in the bloodstream—T cells also move with the same velocity as other cells in the blood so they tend to get lost in the crush.

To flush them out, von Andrian, Manjunath, and their colleagues created a mouse in which immature T cells were equipped, by genetic means, with a green fluorescent tag. Normally, immature, or naive, T cells learn to identify bits of foreign invaders, called antigens, early on, but develop into fully effective killer T cells—complete with the cellular machinery to kill—only when they encounter actual infection. To coax the quiescent killer T cells into their fully effective state, the researchers infected the mice with a virus. Upon reaching full maturity, almost all of the cells lost their green tag—essentially revealing themselves by becoming invisible.

Why the green light goes out in the mature T cells is not clear but it could be a by-product of other changes occurring inside the differentiating T cells—perhaps the removal of factors that help to drive green fluorescent protein expression. Some or all of these factors may control other genes which need to be turned off in order for the killer T cell to differentiate. Identifying these factors and the genes they control will be "a milestone forward towards understanding how killer T cells develop," says Manjunath.


Adapted from materials provided by Harvard Medical School.
APA

MLA

Search ScienceDaily

Number of stories in archives: 44,032

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.
 

Science Video News


Beating Bone Marrow Cancer

To lessen the impact of chemotherapy on bone marrow cancer patients, hematologists are recruiting the patients' own immune systems to help. White. ...  > full story

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of the new ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Cite this article in your essay, paper, or report:
close
Email this page's link to a friend or colleague:
close